A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents.

Dodsworth, Thomas; Kim, David D; Procyshyn, Ric M; Ross, Colin J; Honer, William G; Barr, Alasdair M

Dodsworth, Thomas; Kim, David D; Procyshyn, Ric M; Ross, Colin J; Honer, William G; Barr, Alasdair M.

Afiliação

Dodsworth T; 1Department of Pharmacology, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC V6T 1Z3 Canada.
Kim DD; 1Department of Pharmacology, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC V6T 1Z3 Canada.
Procyshyn RM; 2Department of Psychiatry, University of British Columbia, Vancouver, BC Canada.
Ross CJ; 3Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC Canada.
Honer WG; 2Department of Psychiatry, University of British Columbia, Vancouver, BC Canada.
Barr AM; 1Department of Pharmacology, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC V6T 1Z3 Canada.

Child Adolesc Psychiatry Ment Health ; 12: 37, 2018.

Article em En | MEDLINE | ID: mdl-30026806

Palavras-chave

2D6; Adolescents; Antipsychotic; Cytochrome P450; Pharmacogenomics; Psychopharmacology; Risperidone

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Child Adolesc Psychiatry Ment Health Ano de publicação: 2018 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google